IP Library › Granted Patent US 10,322,154
Granted Patent B2
US 10,322,154 · App. 15/405,921 · Granted Jun 18, 2019

Sandalwood oil and its uses related to clostridium infections

Inventors: Ian Clements (San Antonio, TX); Paul Castella (San Antonio, TX); Corey Levenson (San Antonio, TX)
Assignee: SANTALIS PHARMACEUTICALS, INC.
A61K36/185A01N65/08A61K45/06Y02A50/469
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,322,154
App. No.
15/405,921
Granted
Jun 18, 2019
Kind
B2
Abstract

Provided herein are methods of using therapeutically effective compositions of sandalwood oil to treat, prevent or reduce the recurrence of Clostridium infections.

Claims (6)

1. A method of reducing the recurrence of a Clostridium infection in a subject in need thereof, comprising administering to the subject a composition comprising a therapeutically effective amount of sandalwood oil, wherein the subject is at risk for recurrence of a Clostridium infection.

2. The method of claim 1 , wherein the infection is in the digestive tract of the subject.

3. The method of claim 1 , wherein the Clostridium infection is a C. difficile infection.

4. The method of claim 1 , wherein the subject has been treated with vancomycin, metronidazole or fidaxomicin.

5. The method of claim 4 , wherein the composition comprising a therapeutically effective amount of sandalwood oil is administered concurrently with or subsequent to treatment with vancomycin, metronidazole or fidaxomicin.

6. The method of claim 5 , wherein the composition comprising a therapeutically effective amount of sandalwood oil is administered subsequent to treatment with vancomycin, metronidazole or fidaxomicin.

Assignments (2)
SECURITY INTEREST Recorded Oct 23, 2018
From: SANTALIS HEALTHCARE CORPORATION; SANTALIS PHARMACEUTICALS, INC.
To: GLOBAL LOAN AGENCY SERVICES AUSTRALIA NOMINEES PTY LTD
Reel/Frame 047282/0532 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2018
From: CLEMENTS, IAN; CASTELLA, PAUL; LEVENSON, COREY
To: SANTALIS PHARMACEUTICALS, INC.
Reel/Frame 044629/0392 →
Continuity (3)
Division 14373810
Provisional Application 61589601 · Jan 23, 2012
Related Publication 20170128509A1 · May 11, 2017